NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024Reid M. Ness, Vaishnavi Sambandam, Christopher T. Chen et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 42
Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Cancer Research|2024Cited by 4